Cheryl Cho-Phan

Medical oncologist, GI specialist

Clinical Assistant Professor, Medicine - Oncology
4.6 out of 5
75 Patient Ratings
10 Patient Comments

Gastrointestinal (GI) Cancer Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic » Getting Here » Make An Appointment

Cancer Center

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Internship: Oregon Health Sciences Univ Hospital (1997) OR

Residency: Oregon Health Sciences Univ Hospital (1999) OR

Fellowship: Stanford University School of Medicine (2002) CA

Medical Education: Georgetown University Hospital (1996) DC

Patient Ratings and Comments

4.7

Friendliness

4.6

Recommended to others

4.7

Explanations

4.7

Listens

4.7

Includes you in decisions

4.7

Clear Communication

4.6

Confidence in your doctor

3.2

Wait times

SHC Patient, Nov 2014

More follow up in regard to the results of labs and radiological studies is needed!

SHC Patient, Nov 2014

Dr. Cho-Phan explained my condition clearly and with respect for my feelings about the return of my disease. She was helpful in reviewing and confirming that I am currently receiving quality care in my own community.

SHC Patient, Nov 2014

Attentive. Informative genuine concern compassionate. Understanding. Professional. Treated me w/respect spoke using language & descriptions I understand.

SHC Patient, Oct 2014

Good experience.

View all 10 patient comments

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score.
Wong, R. J., Devaki, P., Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Clinical gastroenterology and hepatology , 12(9), 1534-1540 e1.

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(9), 1534-U323.

Limitations of Body Surface Area-Based Activity Calculation for Radioembolization of Hepatic Metastases in Colorectal Cancer
Lam, M. Geh., Louie, J. D., Abdelmaksoud, M. Hk., Fisher, G. A., Cho-Phan, C. D., & Sze, D. Y. (2014). Limitations of Body Surface Area-Based Activity Calculation for Radioembolization of Hepatic Metastases in Colorectal Cancer. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 25(7), 1085-1093.

A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal Cancer
Fischer, Ga., Kuo, T., Ramsey, M., Schwartz, E., Rouse, Rv., & Sikic, B. I. (2008). A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal Cancer. CLINICAL CANCER RESEARCH, 14(21), 7074-7079.

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
Koong, A. C., Le, Q. T., Ho, A., Fong, B., Fisher, G., & Bastidas, J. A. (2004). Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 58(4), 1017-1021.

Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies
Advani, R., Fisher, G. A., Lum, B. L., Jambalos, C., Cho, C. D., & Sikic, B. I. (2003). Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies. CLINICAL CANCER RESEARCH, 9(14), 5187-5194.

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer
Mehta, V. K., Cho, C., Ford, J. M., Jambalos, C., Poen, J., & Fisher, G. (2003). Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55(1), 132-137.

4.6 out of 5
75 Patient Ratings
10 Patient Comments

SHC Patient, Nov 2014

More follow up in regard to the results of labs and radiological studies is needed!

SHC Patient, Nov 2014

Dr. Cho-Phan explained my condition clearly and with respect for my feelings about the return of my disease. She was helpful in reviewing and confirming that I am currently receiving quality care in my own community.

SHC Patient, Nov 2014

Attentive. Informative genuine concern compassionate. Understanding. Professional. Treated me w/respect spoke using language & descriptions I understand.

SHC Patient, Oct 2014

Good experience.

SHC Patient, Oct 2014

Dr. Cho is caring and listens to all my health concerns.

SHC Patient, Sep 2014

Great experience always. Always patient with me and spends a lot of time with me answering all my questions.

SHC Patient, Jun 2014

So many patients to deal with makes their job a challenge.

SHC Patient, Apr 2014

The entire team is wonderful.

SHC Patient, Apr 2014

She had not looked at my test results so had no idea that I had some worrying results.

SHC Patient, Mar 2014

Great! Internist!